EC-Logo-2018_TM_CMYK.jpg
electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award
20. November 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness...
EC-Logo-2018_TM_CMYK.jpg
electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis
19. November 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has donated 20 gammaCore...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21
14. November 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Third Quarter 2024 Financial Results
13. November 2024 16:01 ET | electroCore, Inc.
Record quarterly revenues driven by 75% YoY growth of Rx gammaCore™ in the VA/DoD and 147% increase in Truvaga™ sales  Company to host a conference call and webcast today, November 13, 2024 at...
EC-Logo-2018_TM_CMYK.jpg
ElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech Award
12. November 2024 16:01 ET | electroCore, Inc.
ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024
23. Oktober 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
Unyte Health Logo 300ppi.png
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10. Oktober 2024 10:00 ET | Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in Upcoming Investor Conferences
26. September 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
EC-Logo-2018_TM_CMYK.jpg
electroCore Engages FNK IR to Execute Expanded Investor Relations Program
24. September 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...
EC-Logo-2018_TM_CMYK.jpg
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training
10. September 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research...